Focus: Infection Control

Most US cooling towers contain Legionella bacteria

Study finds Legionella bacteria is percent in 84 precent of towers


DNA evidence of Legionella bacteria is present in 164 cooling towers throughout eight of the nine climate regions in the United States, according to an article on the Becker's Clinical Leadership and Infection Control website.

In a study published in PLOS One, researchers took water samples from 196 cooling towers between July and September 2016 — 84 percent (164) contained DNA evidence of Legionella. 

Researchers conducted culture tests on Legionella isolates from 78 of the towers. 

The team identified 144 isolates, about half of which of which were Legionella pneumophilia.

Read the article.

 

 



January 9, 2018


Topic Area: Infection Control


Recent Posts

EV Charging Stations: Planning for Safety, Convenience, Expansion

Managers need to ensure patient access, coordinate with clinical operations and ensure every phase of construction supports the facility's mission.


Why Ambulatory Surgery Centers Are Turning to Dedicated HVAC Systems

Design experts from Neenan Archistruction explain how single-unit HVAC systems for each operating room enhance infection control, comfort, and resiliency.


Ground Broken on UW Health University Row Medical Center

Construction is expected to be completed by the end of 2027.


Better, More Thorough Cleaning Saves Lives

Cleanliness is the first line of defense to protect patients from killer pathogens, but many hospitals refuse to make it a priority.


Encompass Health Opens the Rehabilitation Hospital of Amarillo

The 50-bed inpatient rehabilitation hospital is now accepting patients.


 
 


FREE Newsletter Signup Form

News & Updates | Webcast Alerts
Building Technologies | & More!

 
 
 


All fields are required. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

 
 
 
 

Healthcare Facilities Today membership includes free email newsletters from our facility-industry brands.

Facebook   Twitter   LinkedIn   Posts

Copyright © 2023 TradePress. All rights reserved.